Maravai LifeSciences MRVI
$6.98 −$0.21 (-2.92%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $6.98 0.00%
Open$7.06
Prev close$7.19
Day range$6.91 – $7.17
Volume1.79M
Market cap$1.04B
P/E (TTM)–
Dividend yield–
MRVI Stock News
Headlines matching Maravai LifeSciences or the MRVI ticker, most recent first.
- Craig-Hallum Maintains Maravai LifeSciences(MRVI.US) With Buy Rating
- William Blair Maintains Maravai LifeSciences(MRVI.US) With Hold Rating
- Stifel Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Raises Target Price to $8 Positive
- Deutsche Bank Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Cuts Target Price to $6 Negative
- Craig-Hallum Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Announces Target Price $5
- William Blair Maintains Maravai LifeSciences(MRVI.US) With Hold Rating, Announces Target Price $3.94
- Stifel Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Raises Target Price to $6 Positive
- Guggenheim Maintains Maravai LifeSciences(MRVI.US) With Hold Rating
- Stifel Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Maintains Target Price $4
- Craig-Hallum Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Announces Target Price $10
- Earnings Flash (MRVI) Maravai LifeSciences Holdings, Inc. Posts Q3 Adjusted Loss $0.03 per Share, Vs. FactSet Est of $-0.06 Negative
- Stifel Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Raises Target Price to $9.5 Positive
- KeyBanc Initiates Maravai LifeSciences(MRVI.US) With Buy Rating, Announces Target Price $11
- TD Cowen Initiates Maravai LifeSciences(MRVI.US) With Buy Rating, Announces Target Price $9
- Wells Fargo Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Maintains Target Price $4
No comments yet — be the first to weigh in on MRVI.
Sign in to join the discussion.